Conditions: Sarcoma; Ovarian Neoplasm; Central Nervous System Neoplasm; Thyroid Neoplasm; Carcinoma, Neuroendocrine; Neoplasms, Germ Cell and Embryonal
Intervention: Drug: Pembrolizumab
Sponsors: UNICANCER; National Cancer Institute, France; Ligue contre le cancer, France; Merck Sharp & Dohme Corp.
Not yet recruiting - verified January 2017
How Phenotype Guides Management of the Most Common Malignant Salivary Neoplasms of the Larynx? - Abstract Salivary gland carcinomas of the larynx are uncommon. Adenoid cystic carcinoma is the most prevalent type of salivary gland carcinoma in this reg...